• India
  • +91 98480 35983
  • India
  • USA
  • +1-408-508-5432
  • USA
  • Australia
  • +61-405-871-726
  • Australia
  • or
  • D-U-N-S : 854321383
  • LEI : 9845004484A1C4C82E71
  • MSME : UDYAM-TS-02-0059615

At Rushi Pharma, sourcing is not transactional — it is systematic

Manufacturing Site Verification:

  • Physical verification of manufacturing facility and coordinates
  • Assessment of installed production capacity
  • Capacity utilization analysis
  • Infrastructure and scale validation

Regulatory & Compliance Review:

  • Verification of cGMP systems
  • Review of manufacturing licenses and certifications
  • Audit history assessment (client / regulatory agency audits)
  • Regulatory documentation status

Product Assessment:

  • Manufacturing status (regular / campaign / made-to-order)
  • In-house specifications and Method of Analysis (MOA)
  • Historical price trend evaluation (6–12 months)
  • Commercial sustainability analysis

Quality & Technical Validation:

  • Technical documentation review
  • Pre-shipment samples
  • Third-party analysis (if required)
  • Ongoing technical coordination
  • D-U-N-S: 854321383
  • LEI: 9845004484A1C4C82E71
  • MSME UDYAM-TS-02-0059615
Scroll To Top